Detalhe da pesquisa
1.
Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.
Cancer Sci
; 115(3): 752-762, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254257
2.
Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer.
Cancer Immunol Immunother
; 73(2): 23, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38280026
3.
A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors.
Cancer Immunol Immunother
; 70(2): 337-348, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32757055
4.
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody.
Sci Rep
; 14(1): 11325, 2024 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760458
5.
Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor.
Front Immunol
; 14: 1164724, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207204
6.
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report.
Medicine (Baltimore)
; 101(2): e28339, 2022 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029177
7.
Rare Nivolumab-associated Super Hyper Progressive Disease in Patients With Advanced Gastric Cancer.
In Vivo
; 35(3): 1865-1875, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910874
8.
High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer.
Int J Oncol
; 58(1): 57-69, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367933
9.
A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy.
Medicine (Baltimore)
; 100(23): e25774, 2021 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34114983
10.
Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy.
Anticancer Res
; 41(10): 4985-4993, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593446
11.
High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer.
Oncol Rep
; 44(1): 252-262, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32627041
12.
High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
PLoS One
; 15(1): e0226707, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31923206
13.
Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint Inhibitors.
Anticancer Res
; 39(9): 5195-5201, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31519633